Crypt-Level Tight Junction Remodeling Is Associated with Disease Course and Clinical Outcomes in Inflammatory Bowel...

Area of Science:

• Gastroenterology
• Molecular Biology
• Immunology

Background:

• Intestinal barrier dysfunction, characterized by compromised tight junctions (TJs), is a key feature of inflammatory bowel disease (IBD).
• The clinical relevance of TJ protein remodeling in IBD pathogenesis and prognosis remains incompletely understood.

Purpose of the Study:

• To investigate the association between alterations in key TJ proteins (occludin and claudin-1) expression and localization and disease activity and clinical outcomes in patients with IBD.
• To determine if TJ protein changes correlate with hospitalization, surgery, biologic therapy initiation, and clinical relapse in Crohn's disease (CD) and ulcerative colitis (UC).

Main Methods:

• Retrospective analysis of 100 CD patients, 120 UC patients, and 80 healthy controls.
• Immunohistochemistry to assess occludin and claudin-1 expression and localization (membranous vs. cytoplasmic) in surface and crypt epithelium.
• Logistic and Cox regression models to evaluate associations with clinical outcomes; paired biopsies analyzed for longitudinal changes.

Main Results:

• Increased occludin and claudin-1 expression and cytoplasmic redistribution in crypts were observed in active IBD, correlating with disease severity.
• In CD, crypt occludin overexpression predicted hospitalization and surgery; irregular staining predicted biologic therapy initiation.
• In UC, increased crypt occludin levels and irregular staining predicted hospitalization; higher levels predicted relapse. TJ architecture improved in paired biopsies.

Conclusions:

• Tight junction remodeling, especially occludin dysregulation within intestinal crypts, is significantly associated with IBD disease activity.
• These TJ alterations represent a clinically relevant aspect of epithelial barrier dysfunction and are linked to adverse clinical outcomes in IBD patients.